Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-29

Clinical Trial Update: Genetic Architecture of Avoidant/Restrictive Food Intake Disorder

View source ↗

Summary

This completed study investigates the genetic architecture of Avoidant/Restrictive Food Intake Disorder (ARFID) to better understand its biology.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: ARFID, Eating Disorders | Status: COMPLETED